Adriann Sax

Adriann Sax

Oprichter bij
Vetigenics LLC
65 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

Adriann W.
Sax
is the founder of Vetigenics LLC, serving as President, Chief Executive Officer & Director since 2017.
Former positions include Chief Executive Officer & Director at Orsenix LLC from 2019 to 2020, Executive Director-Oncology at Merck & Co., Inc., Director at Healthcare Businesswomen Association, Independent Director at QSAM Biosciences, Inc. from 2022 to 2024, Vice President-Marketing at Bristol Myers Squibb Co., EVP-Business Development & Strategic Planning at KP Pharmaceuticals LLC, Principal at Sterling Drug, Inc., Chief Business Officer at Symphogen A, Principal at Roche Laboratories, Inc., and Chief Commercial Officer & Executive VP at Kadmon Corp.
LLC.
Education includes an undergraduate degree from the University of Delaware and an MBA from Keller Graduate School of Management.

Actieve functies van Adriann Sax

BedrijvenFunctieBegin
Oprichter 01-01-2017

Eerdere bekende functies van Adriann Sax

BedrijvenFunctieEinde
Directeur/Bestuurslid 02-05-2024
Algemeen Directeur 01-01-2020
Corporate Officer/Principal -
Corporate Officer/Principal -
Directeur/Bestuurslid -
Ervaring van Adriann Sax in detail bekijken

Opleiding van Adriann Sax

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

9

Eerstegraads connecties

13

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit13

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Non-Durables

Consumer Services

Health Technology

Distribution Services

Consumer Services

Health Technology

Process Industries

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Adriann Sax